Trading Concept
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Trading Concept
No Result
View All Result
Home Trading News

Biden expected to pick former FDA Commissioner Dr. Robert Califf to run the agency

by
November 12, 2021
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Sam Altman didn’t take any equity in OpenAI, report says

‘It was agony’: Why SVB’s collapse is especially hard as a Black founder, says CEO

Dr. Robert Califf testifies during his nomination hearing before the Senate Health, Education, Labor and Pensions Committee November 17, 2015 in Washington, DC.

Win McNamee | Getty Images

President Joe Biden is expected to pick Dr. Robert Califf to serve as the chief of the Food and Drug Administration, NBC News reported Friday, citing people familiar with the selection process.

The FDA, currently overseen by acting Commissioner Dr. Janet Woodcock, has been without a permanent chief since Biden took office in January. The White House reportedly ruled out Woodcock after she faced opposition from some members of Congress over her handling of opioids while at the agency.

Califf, a cardiologist who works at the Duke University School of Medicine, was briefly the agency’s commissioner under the Obama administration beginning in 2016. He also served as deputy commissioner of the FDA’s medical products and tobacco office.

The new selection is expected imminently because Woodcock cannot legally stay on as the acting head past Nov. 15 without a nominee to hold the position permanently.

Biden’s expected nomination comes amid the ongoing Covid-19 pandemic, which has killed at least 759,678 Americans, according to data compiled by Johns Hopkins University.

The FDA has helped bring lifesaving treatments to the market and authorized the use of Covid vaccines, which have shown to be highly effective, especially against severe disease, hospitalization and death.

More than 194 million Americans are fully vaccinated against Covid, according to data compiled by the Centers for Disease Control and Prevention.

The FDA has recently come under harsh criticism, though, over its decision to approve Biogen’s Alzheimer’s drug, Aduhelm.

ShareTweetPin

Related Posts

Sam Altman didn’t take any equity in OpenAI, report says

by
March 24, 2023
0

Sam Altman, president of Y Combinator, pauses during the New Work Summit in Half Moon Bay, California, U.S., on Monday,...

‘It was agony’: Why SVB’s collapse is especially hard as a Black founder, says CEO

by
March 24, 2023
0

Isa Watson, founder of voice-only social messaging app Squad, was on a plane when she got the news: Silicon Valley...

Europe’s leaders battle banking crisis as market rout hangs over Brussels summit

by
March 24, 2023
0

In this article .BBKADBCSG.N-CH Follow your favorite stocksCREATE FREE ACCOUNT Germany's Chancellor Olaf Scholz said Deutsche Bank is profitable after...

BofA’s Hartnett sees commercial real estate as the ‘next shoe to drop’

by
March 24, 2023
0

Commercial real estate could be the next danger spot in the wobbly U.S. financial sector, according to Bank of America....

TikTok wants to distance itself from China — but Beijing is getting involved

by
March 24, 2023
0

China and U.S. flags are seen near a TikTok logo in this illustration picture taken July 16, 2020. Florence Lo...

Next Post

Q4 GDP Forecasts: Around 5% to 6%

Why This IBM Spinoff Is Struggling

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • WHO says Covid vaccine booster programs will prolong pandemic

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Spin or Split? AT&T Has a Big Decision to Make on Discovery Stake.

    0 shares
    Share 0 Tweet 0
  • Here’s how Carl Icahn is positioning for a possible recession in America

    0 shares
    Share 0 Tweet 0
  • Some lawmakers and their families are betting thousands of dollars on crypto

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by tradingconcept.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.tradingconcept.net